“Our experience with the COVID-19 pandemic exposed challenges in accessing diagnostic testing kits, availability of vaccines, and pandemic preparedness. It highlighted the need to improve self-sufficiency and establish capacity to manufacture vaccines,” said ADB Principal Health Specialist Dinesh Arora. The manufacturing facility is committed to promoting gender equality and social inclusion, incorporating green and resilient production practices that prioritise energy efficiency, reduced material usage, waste reduction, and lower carbon emissions, the ADB said. Certification from the World Health Organization for good manufacturing practices will also be sought for the facility. The loan will support the Directorate General of Drug Administration to enhance its regulatory capacity to achieve WHO maturity level 3 and beyond, according to the ADB.

Source: bd News24 November 22, 2023 12:25 UTC